Results 11 to 20 of about 18,201 (217)

Inherited Epidermolysis Bullosa: Update on the Clinical and Genetic Aspects [PDF]

open access: yesAnais Brasileiros De Dermatologia, 2020
Inherited epidermolysis bullosa is a group of genetic diseases characterized by skin fragility and blistering on the skin and mucous membranes in response to minimal trauma.
Juliana Tosetto Santin   +2 more
exaly   +3 more sources

Dystrophic Epidermolysis Bullosa

open access: yesJournal of Nepal Medical Association, 2018
Epidermolysis bullosa is a rare inherited blistering disease with an incidence of 8-10 per million live births. Dystrophic epidermolysis bullosa is a type of epidermolysis bullosa caused by mutation in type VII collagen, COL7A1.
Randhir Sagar Yadav   +4 more
doaj   +2 more sources

Epidermolysis Bullosa—A Different Genetic Approach in Correlation with Genetic Heterogeneity

open access: yesDiagnostics, 2022
Epidermolysis bullosa is a heterogeneous group of rare genetic disorders characterized by mucocutaneous fragility and blister formation after minor friction or trauma. There are four major epidermolysis bullosa types based on the ultrastructural level of
Monica-Cristina Pânzaru   +4 more
doaj   +2 more sources

Acute renal failure in a patient with epidermolysis bullosa acquisita [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
: Epidermolysis bullosa acquisita is a severe autoimmune subepidermal bullous disease. In this report, we described for the first time a patient with epidermolysis bullosa acquisita who developed acute renal failure.
Guowei Zhao, Qing Yang, Furen Zhang
doaj   +2 more sources

Dermatofibrosarcoma protuberans in a young patient with epidermolysis bullosa: a case report

open access: yesBMC Surgery, 2021
Background Epidermolysis bullosa is a group of rare inherited skin diseases characterized by blister formation following mechanical skin trauma. Epidermolysis bullosa is associated with increased skin cancer rates, predominantly squamous cell carcinomas,
B. Bonaventura   +4 more
doaj   +2 more sources

Epidermolysis bullosa acquisita

open access: yesVestnik Dermatologii i Venerologii, 2017
The article describes present-day information on the pathogenesis, clinical picture, treatment and differential diagnostics of epidermolysis bullosa acquisita, an autoimmune skin disease caused by the production of anti-Type VII collagen autoantibodies ...
V. V. Chikin   +3 more
doaj   +2 more sources

SINE Insertion in LAMA3 in Dogs With Junctional Epidermolysis Bullosa. [PDF]

open access: yesAnim Genet
ABSTRACT Junctional epidermolysis bullosa (JEB) is a hereditary skin disorder caused by defects in proteins responsible for dermal‐epidermal adhesion. We investigated the genetic cause of JEB in three related mixed‐breed puppies presenting with congenital skin blistering and ulceration. Whole‐genome sequencing of one affected dog followed by comparison
Kiener S   +4 more
europepmc   +2 more sources

Metaplastic Conditions in The Bladder in Patient With Epidermolysis Bullosa

open access: yesInternational Brazilian Journal of Urology
Epidermolysis bullosa is a rare inherited muco-cutaneous disorder that sometimes presents with genitourinary involvement. Herein we report the case of an 11-year-old girl with a history of junctional epidermolysis bullosa who was admitted with urological
Kenan Yilmaz   +3 more
doaj   +2 more sources

Junctional epidermolysis bullosa: genotype-phenotype correlations [PDF]

open access: yesVestnik Dermatologii i Venerologii, 2023
Junctional epidermolysis bullosa most commonly results from mutations in the LAMA3, LAMB3, LAMC2, COL17A1, ITGA6 and ITGB4 genes. Junctional epidermolysis bullosa is characterized by clinical heterogeneity.
Alexey A. Kubanov   +3 more
doaj   +1 more source

Clinical and epidemiological features of congenital epidermolysis bullosa in the Republic of Dagestan

open access: yesЛечащий Врач, 2022
Congenital epidermolysis bullosa refers to orphan (rare – no more than 10 cases per 100,000 population) diseases. In the Russian Federation, its prevalence rate in 2016 was 3,9 per 1 million population. The objective was to study the clinical and genetic
K. M. Gadzhimuradova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy